The shift in drug manufacturing to overseas locations exposes the pharmaceutical industry to significant risks, including supply chain disruption and financial losses. Policymakers must therefore ...

Safety is a foremost priority of the plasma protein therapeutics industry. The manufacturers of plasma protein therapies, along with the collectors of source plasma, understand the unique nature ...